Is Akebia Therapeutics Inc (AKBA) Stock a Good Value?

Akebia Therapeutics Inc (AKBA) stock has gained 300.00% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives AKBA stock a score of 0 out of a possible 100.

That rank is primarily influenced by a short-term technical score of 0. AKBA's rank also includes a long-term technical score of 0.

AKBA has an Overall Score of 0. Find out what this means to you and get the rest of the rankings on AKBA!

See Full AKBA Report

What's Happening with AKBA Stock Today

Akebia Therapeutics Inc (AKBA) stock is higher by 1.12% while the S&P 500 has fallen -0.02% as of 10:17 AM on Friday, Nov 17. AKBA has gained $0.01 from the previous closing price of $0.99 on volume of 215,443 shares. Over the past year the S&P 500 is higher by 14.21% while AKBA has gained 300.00%. AKBA lost -$0.33 per share in the over the last 12 months. Click Here to get the full Stock Report for Akebia Therapeutics Inc stock.